Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology	Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder	Recruiting	Phase 3	2026-05-07		NCT05625724

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Toulouse	216

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HM Hôpital de la Conception	Marseille	France	1
AP-HM Hôpital Nord	Marseille	France	3
CHI Poissy Saint Germain en Laye	Poissy	France	1
CHRU Nancy	Nancy	France	31
CHU Angers	Angers	France	87
CHU Bordeaux	Bordeaux	France	67
CHU Clermont-Ferrand	Clermont-Ferrand	France	62
CHU Dijon-Bourgogne	Dijon	France	1
CHU Lille	Lille	France	63
CHU Montpellier	Montpellier	France	56
CHU Nantes	Nantes	France	86
CHU Nîmes	Nîmes	France	12
CHU Poitiers	Poitiers	France	70
CHU Rennes	Rennes	France	57
CHU Saint Etienne, Hôpital Nord	Saint-Etienne	France	1
CHU Strasbourg	Strasbourg	France	31
CHU Toulouse	Toulouse	France	76
Groupe hospitalier St Joseph	Paris	France	1
HCL - Groupement Hospitalier Est, Hôpital Femme Mère Enfant	Lyon	France	1
Hôpital Armand - Trousseau	Paris	France	1
Hôpital Cochin	Paris	France	34

Clinical trials